Authors
Latest:
Advances in Head and Neck Cancers Yield New Clinical Implications for NursesAs the treatment paradigm continues to evolve, nurses play a key role in educating patients, monitoring treatments, and watching for adverse effects.
Latest:
Rx Road Map: Amivantamab (Rybrevant) Plus Lazertinib (Lazcluze)APPs provide an in-depth look at amivantamab plus lazertinib for the treatment of patients with locally advanced or metastatic non–small cell lung cancer.
Latest:
Nurses May Advise Patients on Immunotherapy to Increase Fiber IntakeAn expert from The University of Texas MD Anderson Cancer Center offers advice on the best diet to enrich a patient’s microbiome and consequent immunotherapy response.
Latest:
Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment StrategiesExperts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.
Latest:
Cancer Care More Accessible Thanks to Launch of Telehealth and In-Home Infusion programsChevon Rariy, MD, outlines patient eligibility criteria, and the alterations to the nurse patient relationship, as CTCA launches the novel Oncology Clinic at Home Program.
Latest:
Sylvester’s Sexual Health After Cancer Program Expands to Meet Needs of Women with CancerKristin E. Rojas, M.D., FACS, FACOG, assistant professor of surgical oncology in the DeWitt Daughtry Department of Surgery and Sylvester Comprehensive Cancer Center at the University Miami Miller School of Medicine, realized she had struck a chord with women being treated for cancer when she started the Menopause Urogenital Sexual Health and Intimacy Clinic (MUSIC).
Latest:
Why Step-Up Dose With Bispecific Antibodies?Karolina Faysman, NP, explains how step-up dosing is used to reduce CRS and ICANS with bispecific antibodies in multiple myeloma.
Latest:
Recognition of the Advanced Practice Preceptor Role in OncologyA tiered level preceptor recognition program offers a cost-effective organizational intervention designed to acknowledge and incentivize the contributions of advanced practice preceptors.
Latest:
Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in HSCT CareTia Wheatley, DNP, RN, AOCNS, BMTCN, and Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP, discuss the benefits and challenges of multidisciplinary collaboration in hematopoietic stem cell transplant care.
Latest:
Darolutamide Combination May Delay Disease Progression in Metastatic Hormone-Sensitive Prostate CancerAdding darolutamide to androgen deprivation therapy and docetaxel delayed the progression from metastatic hormone-sensitive prostate cancer to metastatic castration-resistant disease.
Latest:
Final Thoughts and Hope for a CurePanelists emphasize the importance of multidisciplinary collaboration, patient education, and advocacy in managing multiple myeloma while expressing optimism about emerging therapies like CAR T cells that offer deeper remissions and improved quality of life.
Latest:
Overcoming The Burden of Guilt as A NurseJanice Post-White, PhD, RN, FAAN, an oncology nurse and caregiver, discusses how she handled the guilt she felt following her son’s leukemia diagnosis.
Latest:
Mehra Details the Importance of PD-L1 Expression in HNSCC Treatment SelectionRanee Mehra, MD, discusses the link between PD-L1 expression and increased immunotherapy efficacy in head and neck squamous cell carcinoma, and what future treatment options may look like for patients in this space.
Latest:
Advanced Practice Providers Are Uniquely Suited for Survivorship CareAdvanced practice providers are the future of survivorship care because of the tremendous value they offer to the practice and its patients.
Latest:
Unmet Needs and Future Directions in the Management of CIMMartin Dietrich, MD, PhD, and Edgardo Santos, MD, FACP, offer closing remarks on unmet needs and future directions in the management of CIM including other disease states where trilaciclib may offer myeloprotective benefit.
Latest:
Subcutaneous Daratumumab Reduces Smoldering Myeloma ProgressionNew AQUILA data show PFS improvement in patients with smoldering multiple myeloma who were treated with subcutaneous daratumumab vs active monitoring.
Latest:
Long-Term Care in ALK+ NSCLCPanelists discuss how they approach long-term monitoring and follow-up care for patients who have ALK-positive+ patients disease to maintain optimal outcomes on stable therapy.
Latest:
Opinion: Increasing Support and Awareness for AYAs With CancerAYA Cancer Awareness Month offers an opportunity for nurses to go further in supporting AYAs with cancer.
Latest:
Advancing CML Management Towards an Ideal Patient JourneyThe panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.
Latest:
Key Takeaways for Patients With MyelofibrosisPatients with myelofibrosis should reflect on their personal priorities and quality of life goals, understand the range of available JAK inhibitor treatment options, and openly communicate with their doctor to arrive at a shared decision for managing their disease.
Latest:
Colorectal Cancer Screening: Education, Advocacy, and ActionIt is essential to continue to develop and incorporate educational strategies to increase screening for colorectal cancer in our communities.
Latest:
Discrepancies Exist Between Actual Care and Trial-Based Recommendations in MCLDiscrepancies exist between actual patterns of care and recommendations based on clinical trials in adult patients with mantle cell lymphoma.
Latest:
Retifanlimab Lengthens Survival for Patients With Anal CancerThe addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell carcinoma of the anal canal.
Latest:
Oncology Drug Crash Course: Tucatinib and Trastuzumab for HER2+ CRCTucatinib was first approved by the FDA for the treatment of patients with HER2-positive advanced unresectable or metastatic breast cancer in combination with trastuzumab and capecitabine on April 17, 2020.
Latest:
Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment StrategiesExperts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.
Latest:
T-Cell Engagers Take Center Stage in Large B-Cell LymphomaBispecific antibodies that engage T cells are an effective treatment modality in relapsed/refractory disease and are an important new treatment for relapsed large B-cell lymphoma.
Latest:
Opinion: Now Is the Time to Optimize Electronic Health Record SystemsBuying one for your practice or enhancing the one you have will help you cut costs and boost your financial stability.
Latest:
Closing Reflection: A Journey of Understanding and ResiliencePanelists discuss how emerging treatments, digital health tools, and enhanced care coordination could streamline disease management and improve quality of life while identifying opportunities to strengthen provider communication and access to resources.
Latest:
Kristin Daly on the Difference Between Somatic and Germline Variants in Precision OncologyKristin M. Daly, MSN, ANP-BC, AOCNP, highlights the difference between somatic and germline variants.
Latest:
Cleveland Clinic Opens New Cancer Center in Abu DhabiThe state-of-the-art facility represents the organization’s vision of global cancer care
